Clark Ian T's Form 4 filing
Olema Pharmaceuticals, Inc. (OLMA) · filed Dec 23, 2025
- Accession no.
- 0001336504-25-000009
- Filed
- Dec 23, 2025
- Trade date
- Dec 19, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 7 non-derivative transactions and 4 derivative transactions. Open-market sales total $7.87M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Clark Ian TCIK 0001336504 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | Common Stock | MOption exerciseAcquired | +209,690 | $4.41 | +$924,732.9 | 209,690 | Direct | |
| Dec 19, 2025 | Common Stock | MOption exerciseAcquired | +21,520 | $3.61 | +$77,687.2 | 231,210 | Direct | |
| Dec 19, 2025 | Common Stock | MOption exerciseAcquired | +21,520 | $7.84 | +$168,716.8 | 252,730 | Direct | |
| Dec 19, 2025 | Common Stock | MOption exerciseAcquired | +12,070 | $4.08 | +$49,245.6 | 264,800 | Direct | |
| Dec 19, 2025 | Common Stock | SSaleDisposed | −29,904 | $28.83 | −$862,132.32 | 234,896 | Direct | |
| Dec 19, 2025 | Common Stock | SSaleDisposed | −193,056 | $29.71 | −$5,735,693.76 | 41,840 | Direct | |
| Dec 19, 2025 | Common Stock | SSaleDisposed | −41,840 | $30.48 | −$1,275,283.2 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | Common Stock | MOption exerciseDisposed | −209,690 | $0.00 | $0 | 0 | Direct | |
| Dec 19, 2025 | Common Stock | MOption exerciseDisposed | −21,520 | $0.00 | $0 | 0 | Direct | |
| Dec 19, 2025 | Common Stock | MOption exerciseDisposed | −21,520 | $0.00 | $0 | 0 | Direct | |
| Dec 19, 2025 | Common Stock | MOption exerciseDisposed | −12,070 | $0.00 | $0 | 12,080 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.